Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SAPTALIS PHARMS

  • FDA Approval
  • June 18, 2024, 15:38 UTC
  • 34
  • 0 comments

FDA approve ACETIC ACID, GLACIAL

Comment Full text

TARO

  • FDA Approval
  • June 18, 2024, 15:38 UTC
  • 34
  • 0 comments

FDA approve DICLOFENAC POTASSIUM

Comment Full text

MYLAN

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 31
  • 0 comments

FDA approve ZALEPLON

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 29
  • 0 comments

FDA approve VENLAFAXINE HYDROCHLORIDE

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 26
  • 0 comments

FDA approve EFINACONAZOLE

Comment Full text

UPSHER SMITH LABS

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 32
  • 0 comments

FDA approve DOXAZOSIN MESYLATE

Comment Full text

APOTEX

  • FDA Approval
  • June 17, 2024, 09:18 UTC
  • 28
  • 0 comments

FDA approve LACOSAMIDE

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • June 14, 2024, 16:54 UTC
  • 23
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

BIOCRYST

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 26
  • 0 comments

FDA approve PERAMIVIR

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • June 14, 2024, 08:41 UTC
  • 21
  • 0 comments

FDA approve POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM SULFATE ANHYDROUS

Comment Full text
  • Previous
  • 328
  • 329
  • 330
  • 331
  • 332
  • Next

Search

News categories

  • Technical Exchange News(10033)
  • Event(412)
  • SEC News(169702)
  • FDA Approval(9405)
  • Company Report(721)
  • Business News(112980)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin